Charterhouse agrees partnership with leading Spanish education group Metrodora

Charterhouse Capital Partners (“Charterhouse”) has agreed to acquire Metrodora, a leading Spanish educational group specializing in training for healthcare professionals.
Charterhouse agrees partnership with leading Spanish education group Metrodora
Charterhouse Capital Partners (“Charterhouse”), one of the longest-established private equity firms operating in Europe, today announces that it has agreed to acquire Metrodora, a leading Spanish educational group, from Magnum Capital. Charterhouse will invest in partnership with Metrodora’s founder, Jordi Roche, to support the next stage of the company’s growth. The transaction is subject to regulatory approval.

Founded in 2021 and headquartered in Madrid, Metrodora is focused on training for healthcare professionals, providing higher education, vocational training, and lifelong learning, spanning fields including nursing, physiotherapy, sports science, and hygiene. 

Charterhouse is investing to help Metrodora extend its strong track record of growth and expansion. Since inception, Metrodora has already developed a highly successful growth platform, integrating 18 educational platforms and opening new centres across Spain and Latin America, to welcome over 25,000 students. 

Charterhouse will leverage its significant experience in the education sector, and in Spain, to support Metrodora in its mission to provide leading educational services across the Spanish and Latin American regions. 

Charterhouse will work closely with Jordi Roche and Metrodora’s management team to deliver the company’s growth strategy, employing Charterhouse’s expertise in industry consolidation, international expansion and building organic growth. Charterhouse will also drive further value creation via the professionalisation of the business. 

The transaction continues a strong period of activity in Spain for Charterhouse, with Metrodora marking its third investment in the country in the past two years, reflecting the firm’s pan-European strategy.

Charterhouse has deep expertise in growing education businesses, with four previous investments in the sector, as well as extensive experience in the healthcare sector. The investment further reinforces Charterhouse’s proven ability to source attractive investment opportunities well in advance of any process, and partner with talented founders and management teams to drive growth. As part of the transaction Jordi Roche will remain a significant investor in the business. 

Pierre de Sarrau, Partner at Charterhouse commented:

“We are delighted to partner with Jordi Roche and Metrodora, a business that we have followed for a long time after identifying its significant growth potential several years ago. This is a high-quality acquisition in our core space, and further strengthens Charterhouse’s approach to investing in attractive, mid-market European companies in our target sectors. Leveraging our significant expertise in the education sector and growth-focused approach, we look forward to driving significant value creation via consolidation and professionalisation in partnership with Jordi and Metrodora’s management team.”

Jordi Roche, Founder at Metrodora remarked:

"I am delighted to partner with Charterhouse, an outstanding private equity firm with extensive expertise in the field of international healthcare education. This partnership will allow us to strengthen Metrodora’s capabilities and drive growth. Together, we will create a new benchmark of excellence and quality in education, while further enhancing the career prospects of our students. Additionally, this partnership will enable us to expand our international presence, equipping us to address global challenges with greater effectiveness. This is an exciting journey ahead, and with the support of Charterhouse, we are well positioned to grow Metrodora into the leading higher education institution in healthcare, sports management and new technologies across Spain and Latin America.” 
LikeDiscussion
Share

Discussion

You are commenting on Charterhouse agrees partnership with leading Spanish education group Metrodora

You must be logged in to add a comment

There are no comments

Be the first to add to the discussion

Charterhouse Capital Partners LLP
Charterhouse Capital Partners LLP
London, United Kingdom
Charterhouse is one of the longest established private equity firms operating in Europe. The firm connects expertise and capital, partnering with ambitious founders and management teams to drive transformational change. Charterhouse has a selective, conviction-led approach to investing in high-quality mid-market European companies across the Services, Healthcare, Specialised Industrials and Consumer sectors. It targets transactions with an enterprise value of between €200m and €1.5bn. Charterhouse’s international team works in an integrated and flexible manner, allowing the firm to combine the skills, knowledge and experience of its entire team to help build successful businesses over the long term. The firm has completed more than 150 acquisitions over 35 years of activity in the European buyout market.
buyoutprivate equity

Related news

Charterhouse Capital Partners announces investment in PHASTAR

Charterhouse Capital Partners announces investment in PHASTAR

Charterhouse Capital Partners LLP ("Charterhouse"), a leading private equity firm, has announced its investment in PHASTAR, a specialist provider of biostatistics and data science services for clinical trials. This partnership will see Charterhouse working alongside PHASTAR's founder and CEO, Kevin Kane, who will retain a significant shareholding and continue leading the company with its existing management team.

Charterhouse Capital Partners LLP
Charterhouse Capital Partners enters into exclusive negotiations for the sale of Cooper to CVC Capital Partners Fund VII and reinvestment in its next stage of growth

Charterhouse Capital Partners enters into exclusive negotiations for the sale of Cooper to CVC Capital Partners Fund VII and reinvestment in its next stage of growth

Charterhouse Capital Partners LLP has entered into exclusive negotiations for the sale of a majority stake in Cooper Consumer Health, a leading European independent over-the-counter (OTC) drug manufacturer and distributor, to CVC Fund VII. The transaction is subject to approval from relevant regulatory authorities and consultation with workers' councils.

Charterhouse Capital Partners LLP